Corey S Goodman is a director of Alx Oncology Holdings Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
RayzeBio, Inc.
21 Sep 23
3
RayzeBio, Inc.
14 Sep 23
4
ALX ONCOLOGY HOLDINGS INC
22 Jun 23
4
ALX ONCOLOGY HOLDINGS INC
16 Jun 22
4
Ventyx Biosciences, Inc.
10 Jun 22
4
Elevation Oncology, Inc.
27 May 22
4
Checkmate Pharmaceuticals, Inc.
17 May 22
4
Checkmate Pharmaceuticals, Inc.
12 May 22
4
Checkmate Pharmaceuticals, Inc.
9 May 22
4
Checkmate Pharmaceuticals, Inc.
4 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Sep 23 | RYZB RayzeBio | Common Stock | Conversion | Acquire C | No | No | 0 | 247,343 | 0.00 | 5,158,162 |
19 Sep 23 | RYZB RayzeBio | Common Stock | Conversion | Acquire C | No | No | 0 | 1,123,862 | 0.00 | 4,910,819 |
19 Sep 23 | RYZB RayzeBio | Common Stock | Conversion | Acquire C | No | No | 0 | 3,786,957 | 0.00 | 3,786,957 |
19 Sep 23 | RYZB RayzeBio | Series C Convertible Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 216,127 | 0.00 | 0 |
19 Sep 23 | RYZB RayzeBio | Series B Convertible Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 1,123,862 | 0.00 | 0 |
19 Sep 23 | RYZB RayzeBio | Series A Convertible Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 3,786,957 | 0.00 | 0 |
20 Jun 23 | ALXO Alx Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 8.14 | 20,200 | 164.43 k | 20,200 |